首页 > 最新文献

Journal of the Intensive Care Society最新文献

英文 中文
Understanding the impact of an online post-ICU peer support group: A survey of patients and families. 了解在线icu后同伴支持小组的影响:对患者和家属的调查。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-11-02 DOI: 10.1177/17511437251381958
Natalie McEvoy, Sabina Mason, Serena O'Brien, Barbara Egan, Melanie Ryberg

Peer support groups for Intensive Care Unit (ICU) survivors and family members hold promising potential to reduce the psychological burden associated with critical illness and increase social support. We invited all ICU survivors and family members who attended an online peer support group in Ireland ('ICUsteps Dublin' open to those across the Island of Ireland) over a five-year period to complete a brief satisfaction survey. Overall, respondents reported high levels of satisfaction. Four key themes emerged from the open-ended responses: decreased feeling of isolation, gaining insight and perspectives, shared experiences and suggestions for improvement.

重症监护室(ICU)幸存者和家庭成员的同伴支持小组在减少与危重疾病相关的心理负担和增加社会支持方面具有很大的潜力。我们邀请了所有参加爱尔兰在线同伴支持小组的ICU幸存者和家庭成员(“ICUsteps Dublin”对爱尔兰岛各地的人开放),为期五年,完成一项简短的满意度调查。总体而言,受访者的满意度很高。从开放式答复中产生了四个关键主题:减少孤立感、获得洞察力和观点、分享经验和改进建议。
{"title":"Understanding the impact of an online post-ICU peer support group: A survey of patients and families.","authors":"Natalie McEvoy, Sabina Mason, Serena O'Brien, Barbara Egan, Melanie Ryberg","doi":"10.1177/17511437251381958","DOIUrl":"10.1177/17511437251381958","url":null,"abstract":"<p><p>Peer support groups for Intensive Care Unit (ICU) survivors and family members hold promising potential to reduce the psychological burden associated with critical illness and increase social support. We invited all ICU survivors and family members who attended an online peer support group in Ireland ('ICUsteps Dublin' open to those across the Island of Ireland) over a five-year period to complete a brief satisfaction survey. Overall, respondents reported high levels of satisfaction. Four key themes emerged from the open-ended responses: decreased feeling of isolation, gaining insight and perspectives, shared experiences and suggestions for improvement.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"17511437251381958"},"PeriodicalIF":1.4,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12583009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of appropriate empiric antimicrobial therapy with acute kidney injury in gram-negative sepsis. 适当的经验性抗菌药物治疗与革兰氏阴性败血症急性肾损伤的关系。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-10-09 eCollection Date: 2026-02-01 DOI: 10.1177/17511437251377990
Tetsu Ohnuma, Shreya Khandelwal, Shingo Chihara, Miriam Treggiari, Jamie R Privratsky, Pattrapun Wongsripuemtet, Julia A Messina, Karthik Raghunathan, Vijay Krishnamoorthy

Background: Despite advances in sepsis management, the relationship between appropriate empiric antibiotic therapy and acute kidney injury (AKI) in sepsis remains unclear. This study aimed to examine the association of appropriate empiric antimicrobial therapy with AKI in early onset sepsis caused by gram-negative bloodstream infections.

Methods: We conducted a retrospective study of gram-negative bloodstream infection episodes in adult patients with early onset sepsis, using the Premier Healthcare Database from 2016 to 2020. The exposure was appropriate empiric antibiotic therapy determined by antibiotic regiments and antimicrobial susceptibilities of pathogens. The primary outcome was development of AKI or death by day 7 after the onset of sepsis. AKI was defined using the Kidney Disease Improving Global Outcome criteria based on serum creatinine levels, as urine output data were not available. The multivariable regression analysis was used to examine the association between appropriate empiric antibiotic therapy and the outcomes.

Results: We identified 8565 patients with gram negative sepsis. In the total sample, the proportion of appropriate empiric antibiotic therapy was 93.2%, and the prevalence of AKI was 85.3%. Appropriate empiric antibiotic therapy was associated with decreased risk of AKI or death (adjusted odds ratio 0.70, 95% CI 0.52-0.94). For secondary outcomes, appropriate empiric antibiotic therapy was associated with lower AKI, shorter hospital LOS, lower C. difficile infections. However, it was not associated with in-hospital mortality.

Conclusion: Appropriate empiric antibiotic therapy was associated with lower AKI in gram-negative sepsis. Early administration of appropriate antibiotics may prevent development of AKI.

背景:尽管脓毒症治疗取得了进展,但适当的经院性抗生素治疗与脓毒症急性肾损伤(AKI)之间的关系仍不清楚。本研究旨在探讨在革兰氏阴性血流感染引起的早期脓毒症中,适当的经验性抗菌药物治疗与AKI的关系。方法:我们利用2016年至2020年的Premier Healthcare数据库,对早发性脓毒症成年患者的革兰氏阴性血流感染事件进行了回顾性研究。暴露是适当的经验性抗生素治疗,由抗生素团和病原体的抗菌药物敏感性决定。主要终点是脓毒症发病后第7天AKI的发展或死亡。由于尿量数据不可用,AKI的定义采用基于血清肌酐水平的肾脏疾病改善全球结局标准。使用多变量回归分析来检验适当的经验性抗生素治疗与结果之间的关系。结果:我们确定了8565例革兰氏阴性脓毒症患者。在总样本中,适当的经验性抗生素治疗比例为93.2%,AKI患病率为85.3%。适当的经验性抗生素治疗与AKI或死亡风险降低相关(校正优势比0.70,95% CI 0.52-0.94)。对于次要结果,适当的经验性抗生素治疗与较低的AKI、较短的医院LOS和较低的艰难梭菌感染相关。然而,它与住院死亡率无关。结论:适当的经验性抗生素治疗可降低革兰氏阴性脓毒症患者的AKI。早期给予适当的抗生素可以预防AKI的发展。
{"title":"Association of appropriate empiric antimicrobial therapy with acute kidney injury in gram-negative sepsis.","authors":"Tetsu Ohnuma, Shreya Khandelwal, Shingo Chihara, Miriam Treggiari, Jamie R Privratsky, Pattrapun Wongsripuemtet, Julia A Messina, Karthik Raghunathan, Vijay Krishnamoorthy","doi":"10.1177/17511437251377990","DOIUrl":"10.1177/17511437251377990","url":null,"abstract":"<p><strong>Background: </strong>Despite advances in sepsis management, the relationship between appropriate empiric antibiotic therapy and acute kidney injury (AKI) in sepsis remains unclear. This study aimed to examine the association of appropriate empiric antimicrobial therapy with AKI in early onset sepsis caused by gram-negative bloodstream infections.</p><p><strong>Methods: </strong>We conducted a retrospective study of gram-negative bloodstream infection episodes in adult patients with early onset sepsis, using the Premier Healthcare Database from 2016 to 2020. The exposure was appropriate empiric antibiotic therapy determined by antibiotic regiments and antimicrobial susceptibilities of pathogens. The primary outcome was development of AKI or death by day 7 after the onset of sepsis. AKI was defined using the Kidney Disease Improving Global Outcome criteria based on serum creatinine levels, as urine output data were not available. The multivariable regression analysis was used to examine the association between appropriate empiric antibiotic therapy and the outcomes.</p><p><strong>Results: </strong>We identified 8565 patients with gram negative sepsis. In the total sample, the proportion of appropriate empiric antibiotic therapy was 93.2%, and the prevalence of AKI was 85.3%. Appropriate empiric antibiotic therapy was associated with decreased risk of AKI or death (adjusted odds ratio 0.70, 95% CI 0.52-0.94). For secondary outcomes, appropriate empiric antibiotic therapy was associated with lower AKI, shorter hospital LOS, lower C. difficile infections. However, it was not associated with in-hospital mortality.</p><p><strong>Conclusion: </strong>Appropriate empiric antibiotic therapy was associated with lower AKI in gram-negative sepsis. Early administration of appropriate antibiotics may prevent development of AKI.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"41-47"},"PeriodicalIF":1.4,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to "Guidance for: The acute management of status epilepticus in adult patients". “成人患者癫痫持续状态的急性管理指南”的勘误。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-10-08 eCollection Date: 2025-08-01 DOI: 10.1177/17511437251347396

[This corrects the article DOI: 10.1177/17511437251321338.].

[这更正了文章DOI: 10.1177/17511437251321338.]。
{"title":"Erratum to \"Guidance for: The acute management of status epilepticus in adult patients\".","authors":"","doi":"10.1177/17511437251347396","DOIUrl":"https://doi.org/10.1177/17511437251347396","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/17511437251321338.].</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"26 3","pages":"408"},"PeriodicalIF":1.4,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12508536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do-not-attempt-cardiopulmonary resuscitation decisions in critical care: The gap between theory and practice. 不尝试心肺复苏在重症监护中的决定:理论与实践之间的差距。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-10-07 DOI: 10.1177/17511437251369306
Prashanth Nandhabalan, Thearina de Beer, Robert Tobin, Dan Harvey, Richard Innes, Aaron D'Sa, Victoria Metaxa

The provision or withholding of Cardiopulmonary Resuscitation (CPR) is often a source of much controversy. Do-Not-Attempt CPR (DNACPR) decisions have been discussed extensively from an ethical and legal point, not to mention featuring heavily in the news. We aim to discuss various aspects of DNACPR decision-making with particular relevance to the Intensive Care environment. In doing so, we highlight important concepts associated with decision-making and common challenges encountered. Firstly, we provide a broad oversight of the current context in which such decisions are made before describing the principal ethical points of consideration and their relevance. This is followed by insights from a legal point as well as practical suggestions for approaching such decisions. It is hoped that these will help to assist clinicians with making such complex decisions under challenging circumstances.

提供或停止心肺复苏(CPR)往往是一个争议的来源。不尝试心肺复苏术(DNACPR)的决定已经从道德和法律的角度进行了广泛的讨论,更不用说在新闻中大量出现了。我们的目标是讨论DNACPR决策的各个方面,特别是与重症监护环境相关。在此过程中,我们强调与决策有关的重要概念和遇到的共同挑战。首先,在描述主要的伦理考虑点及其相关性之前,我们提供了对当前环境的广泛监督,在这种环境中做出此类决定。其次是从法律角度的见解以及处理此类决定的实际建议。希望这些将有助于帮助临床医生在具有挑战性的情况下做出如此复杂的决定。
{"title":"Do-not-attempt-cardiopulmonary resuscitation decisions in critical care: The gap between theory and practice.","authors":"Prashanth Nandhabalan, Thearina de Beer, Robert Tobin, Dan Harvey, Richard Innes, Aaron D'Sa, Victoria Metaxa","doi":"10.1177/17511437251369306","DOIUrl":"10.1177/17511437251369306","url":null,"abstract":"<p><p>The provision or withholding of Cardiopulmonary Resuscitation (CPR) is often a source of much controversy. Do-Not-Attempt CPR (DNACPR) decisions have been discussed extensively from an ethical and legal point, not to mention featuring heavily in the news. We aim to discuss various aspects of DNACPR decision-making with particular relevance to the Intensive Care environment. In doing so, we highlight important concepts associated with decision-making and common challenges encountered. Firstly, we provide a broad oversight of the current context in which such decisions are made before describing the principal ethical points of consideration and their relevance. This is followed by insights from a legal point as well as practical suggestions for approaching such decisions. It is hoped that these will help to assist clinicians with making such complex decisions under challenging circumstances.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"17511437251369306"},"PeriodicalIF":1.4,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12507786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of corticosteroids in the management of non-COVID-19 severe community-acquired pneumonia in the intensive care unit: A narrative review. 皮质类固醇在重症监护病房非covid -19重症社区获得性肺炎管理中的作用:一项叙述性综述
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-27 eCollection Date: 2026-02-01 DOI: 10.1177/17511437251374816
Isis Terrington, Olivia Cox, Patrick Copley, Benjamin Eastwood, Elizabeth Webb, Cathrine McKenzie, Kordo Saeed, Andrew Conway-Morris, Michael P W Grocott, Ahilanandan Dushianthan

Severe community-acquired pneumonia (sCAP) is associated with a significant health burden, both in the UK and globally, with intensive care support needed for many patients. The high morbidity and mortality associated with sCAP has led to the exploration of adjunctive therapies that may help reduce disease burden and improve clinical outcomes. One such proposed treatment is corticosteroids, aiming to moderate the disproportionate inflammation caused by sCAP. Despite several studies suggesting potential benefits, the use of corticosteroids in patients with sCAP remains contentious, with recent large trials producing conflicting results. These variations in trial outcomes have resulted in conflicting national and international guidelines. Such discrepancies align with findings from a recent national survey that indicated ongoing clinical uncertainty regarding the use of corticosteroids for sCAP in UK intensive care units. Several factors contribute to these conflicting outcomes, including patient population, the severity classification utilised, the type and duration of interventions provided, and, perhaps most importantly, the lack of pre-phenotyping to identify patients who may benefit most from the treatment. This narrative review aims to examine the recent literature, current guidelines, and evidence for using corticosteroids in sCAP, while exploring the candidate phenotypes of relevance in the design of clinical trials.

无论是在英国还是在全球,严重社区获得性肺炎(sCAP)都与重大的健康负担相关,许多患者需要重症监护支持。sCAP相关的高发病率和死亡率促使人们探索辅助疗法,以帮助减轻疾病负担和改善临床结果。其中一种建议的治疗方法是皮质类固醇,旨在缓解sCAP引起的不成比例的炎症。尽管有几项研究表明了潜在的益处,但在sCAP患者中使用皮质类固醇仍然存在争议,最近的大型试验产生了相互矛盾的结果。这些试验结果的差异导致了国家和国际指南的冲突。这种差异与最近一项全国调查的结果一致,该调查表明,在英国重症监护病房中,使用皮质类固醇治疗sCAP的临床不确定性持续存在。有几个因素导致了这些相互矛盾的结果,包括患者群体、使用的严重程度分类、提供的干预措施的类型和持续时间,也许最重要的是,缺乏预先表型来识别可能从治疗中获益最多的患者。这篇叙述性综述的目的是检查最近的文献,当前的指南,以及在sCAP中使用皮质类固醇的证据,同时探索临床试验设计中相关的候选表型。
{"title":"The role of corticosteroids in the management of non-COVID-19 severe community-acquired pneumonia in the intensive care unit: A narrative review.","authors":"Isis Terrington, Olivia Cox, Patrick Copley, Benjamin Eastwood, Elizabeth Webb, Cathrine McKenzie, Kordo Saeed, Andrew Conway-Morris, Michael P W Grocott, Ahilanandan Dushianthan","doi":"10.1177/17511437251374816","DOIUrl":"10.1177/17511437251374816","url":null,"abstract":"<p><p>Severe community-acquired pneumonia (sCAP) is associated with a significant health burden, both in the UK and globally, with intensive care support needed for many patients. The high morbidity and mortality associated with sCAP has led to the exploration of adjunctive therapies that may help reduce disease burden and improve clinical outcomes. One such proposed treatment is corticosteroids, aiming to moderate the disproportionate inflammation caused by sCAP. Despite several studies suggesting potential benefits, the use of corticosteroids in patients with sCAP remains contentious, with recent large trials producing conflicting results. These variations in trial outcomes have resulted in conflicting national and international guidelines. Such discrepancies align with findings from a recent national survey that indicated ongoing clinical uncertainty regarding the use of corticosteroids for sCAP in UK intensive care units. Several factors contribute to these conflicting outcomes, including patient population, the severity classification utilised, the type and duration of interventions provided, and, perhaps most importantly, the lack of pre-phenotyping to identify patients who may benefit most from the treatment. This narrative review aims to examine the recent literature, current guidelines, and evidence for using corticosteroids in sCAP, while exploring the candidate phenotypes of relevance in the design of clinical trials.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"119-133"},"PeriodicalIF":1.4,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution of mortality from sepsis in patients with cancer: A systematic review and meta-analysis. 癌症患者败血症死亡率的演变:一项系统回顾和荟萃分析。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-27 eCollection Date: 2026-02-01 DOI: 10.1177/17511437251363762
Luke Edwards, Elizabeth Nelmes, Maddalena Ardissino, Helen Lin Jia Qi, Shaman Jhanji, David B Antcliffe, Kate C Tatham

Background: Increasing numbers of patients with cancer are being admitted to intensive care units (ICU) with sepsis. The mortality from sepsis and septic shock in these patients is unclear. This study aimed to establish mortality from sepsis and septic shock in patients with cancer admitted to ICU and assess mortality trends over time.

Methods: We conducted a literature search using MEDLINE and EMBASE. Included studies enrolled adult patients with cancer admitted to ICU with sepsis or septic shock and reported outcomes of interest. Studies were assessed using the Newcastle-Ottawa Scale for risk of bias and the quality assessment tool for observational cohort and cross-sectional studies. We performed a meta-analysis to estimate pooled ICU, hospital and 30-day mortality from sepsis and septic shock and a multivariate meta-regression to assess mortality trends over time. The study was registered on PROSPERO (CRD42022341277).

Results: Twenty-five articles were included. The pooled ICU, hospital and 30-day mortality for sepsis was 44% (95% CI 38%-50%), 54% (95% CI 49%-60%) and 49% (95% CI 44%-55%) respectively. The pooled ICU, hospital and 30-day mortality for septic shock was 51% (95% CI 45%-57%), 62.6% (95% CI 56%-69%) and 54% (95% CI 46%-61%) respectively. There was significant heterogeneity between studies. The meta-regression identified decreasing ICU and hospital mortality from sepsis, and decreasing ICU mortality from septic shock.

Conclusion: Patients with cancer admitted to ICU with sepsis face a significant mortality risk greater than that of the general population, despite decreasing mortality over time. Further research is required to improve outcomes.

背景:越来越多的癌症患者因脓毒症被送进重症监护病房(ICU)。这些患者脓毒症和感染性休克的死亡率尚不清楚。本研究旨在确定ICU收治的癌症患者脓毒症和感染性休克的死亡率,并评估死亡率随时间的变化趋势。方法:采用MEDLINE和EMBASE进行文献检索。纳入的研究纳入了因脓毒症或脓毒性休克入住ICU的成年癌症患者,并报告了感兴趣的结果。研究使用纽卡斯尔-渥太华量表评估偏倚风险,并使用观察队列和横断面研究的质量评估工具评估。我们进行了荟萃分析来估计ICU、医院和脓毒症和感染性休克的30天死亡率,并进行了多变量荟萃回归来评估死亡率随时间的趋势。该研究已在PROSPERO注册(CRD42022341277)。结果:共纳入25篇文章。ICU、医院和30天脓毒症的总死亡率分别为44% (95% CI 38%-50%)、54% (95% CI 49%-60%)和49% (95% CI 44%-55%)。脓毒性休克在ICU、医院和30天的总死亡率分别为51% (95% CI 45%-57%)、62.6% (95% CI 56%-69%)和54% (95% CI 46%-61%)。研究之间存在显著的异质性。meta回归发现脓毒症ICU死亡率和住院死亡率下降,脓毒症休克ICU死亡率下降。结论:ICU合并脓毒症的癌症患者死亡率明显高于普通人群,尽管死亡率随时间降低。需要进一步的研究来改善结果。
{"title":"The evolution of mortality from sepsis in patients with cancer: A systematic review and meta-analysis.","authors":"Luke Edwards, Elizabeth Nelmes, Maddalena Ardissino, Helen Lin Jia Qi, Shaman Jhanji, David B Antcliffe, Kate C Tatham","doi":"10.1177/17511437251363762","DOIUrl":"10.1177/17511437251363762","url":null,"abstract":"<p><strong>Background: </strong>Increasing numbers of patients with cancer are being admitted to intensive care units (ICU) with sepsis. The mortality from sepsis and septic shock in these patients is unclear. This study aimed to establish mortality from sepsis and septic shock in patients with cancer admitted to ICU and assess mortality trends over time.</p><p><strong>Methods: </strong>We conducted a literature search using MEDLINE and EMBASE. Included studies enrolled adult patients with cancer admitted to ICU with sepsis or septic shock and reported outcomes of interest. Studies were assessed using the Newcastle-Ottawa Scale for risk of bias and the quality assessment tool for observational cohort and cross-sectional studies. We performed a meta-analysis to estimate pooled ICU, hospital and 30-day mortality from sepsis and septic shock and a multivariate meta-regression to assess mortality trends over time. The study was registered on PROSPERO (CRD42022341277).</p><p><strong>Results: </strong>Twenty-five articles were included. The pooled ICU, hospital and 30-day mortality for sepsis was 44% (95% CI 38%-50%), 54% (95% CI 49%-60%) and 49% (95% CI 44%-55%) respectively. The pooled ICU, hospital and 30-day mortality for septic shock was 51% (95% CI 45%-57%), 62.6% (95% CI 56%-69%) and 54% (95% CI 46%-61%) respectively. There was significant heterogeneity between studies. The meta-regression identified decreasing ICU and hospital mortality from sepsis, and decreasing ICU mortality from septic shock.</p><p><strong>Conclusion: </strong>Patients with cancer admitted to ICU with sepsis face a significant mortality risk greater than that of the general population, despite decreasing mortality over time. Further research is required to improve outcomes.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"55-65"},"PeriodicalIF":1.4,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical illness and recovery-learning from the shared experience of survivors and their families: A qualitative study. 危重疾病与康复——从幸存者及其家人的共同经验中学习:一项定性研究。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-27 DOI: 10.1177/17511437251372020
Ceri Lynch, Cheney J G Drew, Sarah Gill, Ceri Battle, Kim Smallman

Background: Improved survival from critical illness in recent years has led to an increase in patients with Post Intensive Care Syndrome (PICS). Routine, dedicated, specific and individualised assessment, rehabilitation and follow-up after critical care discharge is recommended but is currently inadequate in the UK. The aim of this study was to explore patients' and family members' experiences of a critical care admission, focussing on recovery and rehabilitation.

Methods: As part of an intervention development programme, a series of iterative focus groups with survivors of critical illness and their family members was held. Parallel groups with staff involved in the care and rehabilitation of critically ill patients were also conducted. Participants mapped out their recovery journey identifying key moments and challenges and shared their recommendations for recovery and rehabilitation. Brokered dialogue was used to enable patient and staff groups to ask and answer questions of each other. Data analysis was completed using reflexive thematic coding.

Results: Thirty-four participants attended the focus groups, with 28 attending the first two groups discussed in this paper. Using the experiences described by the participants, three overarching themes were identified; fear, helplessness and frustration. Participants also reported both short and longer-term consequences of ICU admission and shared their priorities and advice for recovery and rehabilitation.

Conclusion: Critical care admission is a traumatic experience for patients and family members. Our data highlights patients' needs for ongoing, holistic support during a stay in critical care and beyond.

背景:近年来危重疾病生存率的提高导致重症监护后综合征(PICS)患者的增加。建议在重症监护出院后进行常规、专门、具体和个性化的评估、康复和随访,但目前在英国尚不充分。本研究的目的是探讨病人和家庭成员的经验,重症监护入院,重点是恢复和康复。方法:作为干预发展计划的一部分,与危重疾病幸存者及其家庭成员举行了一系列迭代焦点小组。参与危重病人护理和康复的工作人员也进行了平行组。与会者描绘了他们的康复旅程,确定了关键时刻和挑战,并分享了他们对康复和康复的建议。通过中介对话,病人和工作人员可以互相提问和回答问题。数据分析采用自反性主题编码完成。结果:34名参与者参加了焦点小组,其中28人参加了本文讨论的前两个小组。根据参与者描述的经验,确定了三个总体主题;恐惧、无助和沮丧。参与者还报告了ICU入院的短期和长期后果,并分享了他们对恢复和康复的优先事项和建议。结论:重症监护住院对患者及其家属来说是一种创伤性经历。我们的数据强调了患者在重症监护期间及以后对持续、全面支持的需求。
{"title":"Critical illness and recovery-learning from the shared experience of survivors and their families: A qualitative study.","authors":"Ceri Lynch, Cheney J G Drew, Sarah Gill, Ceri Battle, Kim Smallman","doi":"10.1177/17511437251372020","DOIUrl":"10.1177/17511437251372020","url":null,"abstract":"<p><strong>Background: </strong>Improved survival from critical illness in recent years has led to an increase in patients with Post Intensive Care Syndrome (PICS). Routine, dedicated, specific and individualised assessment, rehabilitation and follow-up after critical care discharge is recommended but is currently inadequate in the UK. The aim of this study was to explore patients' and family members' experiences of a critical care admission, focussing on recovery and rehabilitation.</p><p><strong>Methods: </strong>As part of an intervention development programme, a series of iterative focus groups with survivors of critical illness and their family members was held. Parallel groups with staff involved in the care and rehabilitation of critically ill patients were also conducted. Participants mapped out their recovery journey identifying key moments and challenges and shared their recommendations for recovery and rehabilitation. Brokered dialogue was used to enable patient and staff groups to ask and answer questions of each other. Data analysis was completed using reflexive thematic coding.</p><p><strong>Results: </strong>Thirty-four participants attended the focus groups, with 28 attending the first two groups discussed in this paper. Using the experiences described by the participants, three overarching themes were identified; fear, helplessness and frustration. Participants also reported both short and longer-term consequences of ICU admission and shared their priorities and advice for recovery and rehabilitation.</p><p><strong>Conclusion: </strong>Critical care admission is a traumatic experience for patients and family members. Our data highlights patients' needs for ongoing, holistic support during a stay in critical care and beyond.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"17511437251372020"},"PeriodicalIF":1.4,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical care and the law - pertinent cases from 2024. 从2024年开始的重症监护和法律相关案件。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-25 eCollection Date: 2025-11-01 DOI: 10.1177/17511437251367221
Aaron D'Sa, Robert Tobin, Luigi Camporota, Thearina de Beer, Dan Harvey, Richard Innes, Prashanth Nandhabalan, Victoria Metaxa

This review by the Legal and Ethical Advisory Group (LEAG) follows the 2023 summary, reviewing the important legal cases and Prevention of Future Deaths reports (PFDs) ruled or issued in 2024 that are pertinent to Intensive Care Medicine. The legal cases include Human Rights cases, Clinical Negligence cases, and rulings of the Court of Protection. Not all of the cases relate to events which have occurred in Intensive Care, however the rulings will have a bearing on Intensive Care practice.

法律和伦理咨询小组(LEAG)的这次审查是在2023年总结之后进行的,审查了2024年裁定或发布的与重症监护医学相关的重要法律案件和预防未来死亡报告(pfd)。法律案件包括人权案件、临床过失案件和保护法院的裁决。并非所有的案件都与重症监护室发生的事件有关,但这些裁决将对重症监护室的实践产生影响。
{"title":"Critical care and the law - pertinent cases from 2024.","authors":"Aaron D'Sa, Robert Tobin, Luigi Camporota, Thearina de Beer, Dan Harvey, Richard Innes, Prashanth Nandhabalan, Victoria Metaxa","doi":"10.1177/17511437251367221","DOIUrl":"10.1177/17511437251367221","url":null,"abstract":"<p><p>This review by the Legal and Ethical Advisory Group (LEAG) follows the 2023 summary, reviewing the important legal cases and Prevention of Future Deaths reports (PFDs) ruled or issued in 2024 that are pertinent to Intensive Care Medicine. The legal cases include Human Rights cases, Clinical Negligence cases, and rulings of the Court of Protection. Not all of the cases relate to events which have occurred in Intensive Care, however the rulings will have a bearing on Intensive Care practice.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"496-501"},"PeriodicalIF":1.4,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right ventricular injury during VV-ECMO for severe ARDS: Does time matter? VV-ECMO治疗严重ARDS时右室损伤:时间重要吗?
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-24 eCollection Date: 2026-02-01 DOI: 10.1177/17511437251374821
Robert McDonald, Jo-Anne Fowles, Robert Gatherer, Francisca Caetano

Right ventricular injury (RVI) is a frequent complication during veno-venous extracorporeal membrane oxygenation (VV-ECMO) for severe respiratory failure. In this single-centre retrospective cohort of 40 patients, RVI was observed in 63%, being associated with increased ICU mortality. RVI at admission was more common in younger patients and those with shorter intubation periods pre-cannulation. RVI developing during VV-ECMO was associated with longer ECMO support, ICU stay, and a trend towards higher mortality. The timing of RVI likely reflects different pathophysiology, having different clinical implications. Improved monitoring of right ventricular function during VV-ECMO may enable earlier detection and intervention, potentially improving outcomes.

右心室损伤(RVI)是静脉-静脉体外膜氧合(VV-ECMO)治疗严重呼吸衰竭的常见并发症。在这个40例患者的单中心回顾性队列中,63%的患者观察到RVI,与ICU死亡率增加有关。入院时RVI在年轻患者和插管前插管时间较短的患者中更为常见。VV-ECMO期间发生的RVI与更长的ECMO支持、ICU住院时间和更高的死亡率趋势相关。RVI的时间可能反映了不同的病理生理,具有不同的临床意义。在VV-ECMO期间改善对右心室功能的监测可能有助于早期发现和干预,潜在地改善预后。
{"title":"Right ventricular injury during VV-ECMO for severe ARDS: Does time matter?","authors":"Robert McDonald, Jo-Anne Fowles, Robert Gatherer, Francisca Caetano","doi":"10.1177/17511437251374821","DOIUrl":"10.1177/17511437251374821","url":null,"abstract":"<p><p>Right ventricular injury (RVI) is a frequent complication during veno-venous extracorporeal membrane oxygenation (VV-ECMO) for severe respiratory failure. In this single-centre retrospective cohort of 40 patients, RVI was observed in 63%, being associated with increased ICU mortality. RVI at admission was more common in younger patients and those with shorter intubation periods pre-cannulation. RVI developing during VV-ECMO was associated with longer ECMO support, ICU stay, and a trend towards higher mortality. The timing of RVI likely reflects different pathophysiology, having different clinical implications. Improved monitoring of right ventricular function during VV-ECMO may enable earlier detection and intervention, potentially improving outcomes.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"82-84"},"PeriodicalIF":1.4,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to accreditation in point-of-care echocardiography for critical care: A Scottish perspective. 危重症护理点超声心动图鉴定的障碍:苏格兰视角。
IF 1.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-09-23 eCollection Date: 2026-02-01 DOI: 10.1177/17511437251365176
Helen French, Christopher Leddy, Philip McCall

Point-of-care echocardiography accreditation is not mandated within the Faculty of Intensive Care Medicine (FICM) training curriculum, yet it is commonly utilised to aid clinical decision making in the intensive care unit. We designed a survey to assess barriers to accreditation in point-of-care echocardiography across Scottish critical care units. The majority (70.1%) of respondents were unaccredited, with the most common barrier (n = 102) being 'lack of time with a mentor for supervised scanning'. This was amplified by the fact that only 25% of mentors received job planned time for scanning. Men were over-represented in those with accreditation, accounting for 61.4% of accredited clinicians, despite making up 51.0% of all respondents. In contrast, women represented 62.5% of unaccredited individuals who had undertaken at least one attempt at the process. We did not find a difference with other protected characteristics. This survey suggests that targeted support locally for those struggling to complete the process could address some of these concerns, and that further work needs to be taken to identify and address gender inequity in point of care echocardiography accreditation.

监护点超声心动图认证在重症监护医学系(FICM)培训课程中不是强制性的,但它通常用于帮助重症监护病房的临床决策。我们设计了一项调查,以评估苏格兰重症监护病房即时超声心动图认证的障碍。大多数(70.1%)的受访者没有获得认证,最常见的障碍(n = 102)是“没有时间与导师进行监督扫描”。只有25%的导师得到了工作计划的扫描时间,这一事实进一步放大了这一点。男性在获得认证的临床医生中比例过高,占认证临床医生的61.4%,尽管占所有受访者的51.0%。相比之下,在至少尝试过一次这一过程的未获认证的个人中,女性占62.5%。我们没有发现与其他受保护特征的差异。这项调查表明,在当地为那些努力完成这一过程的人提供有针对性的支持可以解决其中的一些问题,并且需要采取进一步的工作来识别和解决护理点超声心动图认证中的性别不平等问题。
{"title":"Barriers to accreditation in point-of-care echocardiography for critical care: A Scottish perspective.","authors":"Helen French, Christopher Leddy, Philip McCall","doi":"10.1177/17511437251365176","DOIUrl":"10.1177/17511437251365176","url":null,"abstract":"<p><p>Point-of-care echocardiography accreditation is not mandated within the Faculty of Intensive Care Medicine (FICM) training curriculum, yet it is commonly utilised to aid clinical decision making in the intensive care unit. We designed a survey to assess barriers to accreditation in point-of-care echocardiography across Scottish critical care units. The majority (70.1%) of respondents were unaccredited, with the most common barrier (<i>n</i> = 102) being 'lack of time with a mentor for supervised scanning'. This was amplified by the fact that only 25% of mentors received job planned time for scanning. Men were over-represented in those with accreditation, accounting for 61.4% of accredited clinicians, despite making up 51.0% of all respondents. In contrast, women represented 62.5% of unaccredited individuals who had undertaken at least one attempt at the process. We did not find a difference with other protected characteristics. This survey suggests that targeted support locally for those struggling to complete the process could address some of these concerns, and that further work needs to be taken to identify and address gender inequity in point of care echocardiography accreditation.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":" ","pages":"85-89"},"PeriodicalIF":1.4,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Intensive Care Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1